People
Just what do those in favor of the H.R. 3 - organizations, individuals, companies and institutions - have to say?
Most of the jobs are field-based positions across the U.S., although some will be in Thousand Oaks, California at the company’s headquarters.
Akelos Inc., a biotechnology company currently developing and commercializing a novel, non-opioid anti-hyperalgesic drug to treat chronic and neuropathic pain, adds Dr. Heffner, the former Executive Director of Neuroscience and Pain Business Development at Pfizer, as a Strategic Advisor.
Shaun Grannis, M.D., M.S., an internationally recognized expert in informatics, data analytics, and biosurveillance, has been named the Regenstrief Institute’s first vice president of data and analytics.
If successful, the CEO told BioSpace in an exclusive interview that Acelarin will break the glass ceiling as the first FDA-approved treatment for biliary tract cancer.
Balancing slim chances with a drive for success, each of these women beat the biotech odds.
On Monday, the U.S. Supreme Court refused to overturn his seven-year conviction for securities fraud.
Industry veterans including Craig Lipset will support the Castor’s vision to advance the future of clinical research
Board includes experts from Case Western Reserve University, Duke University, University of Pittsburgh and Washington University in St. Louis
People deserve a personalized approach in cancer treatment that considers their unique genetic traits and the latest medical research — this methodology stands a significantly increased chance of pushing back against the disease.
PRESS RELEASES